Pasupati Acrylon PAT Skyrockets 1465% in June 2026 Quarter
By ThePip Desk
Pasupati Acrylon reports a staggering 1465.14% PAT surge to Rs 273.90M in June 2026 quarter. Revenue up 10.28%, PBIDT surges 383%.
Pasupati Acrylon recorded a substantial 1465.14% increase in Profit After Tax (PAT) for the quarter ending June 2026, reaching Rs 273.90 million. This marks a significant jump from Rs 17.50 million in the corresponding quarter last year, highlighting robust financial performance.
The company also saw its revenue climb to Rs 2382.60 million, an increase of 10.28% compared to Rs 2160.50 million in the same quarter of the previous year.
Pasupati Acrylon’s Key Financial Metrics
- Sales for June 2026 quarter: Rs 2382.60 million, up 10.28% from Rs 2160.50 million in June 2025.
- Other Income rose to Rs 30.70 million, a 14.13% increase from Rs 26.90 million.
- PBIDT (Operating Profit) surged to Rs 421.00 million, compared to Rs 87.10 million in the prior year quarter, demonstrating strong operational efficiency.
- Interest expenses decreased by 31.93% to Rs 22.60 million from Rs 33.20 million.
- Profit Before Tax (PBT) reached Rs 366.90 million, a remarkable 1428.75% growth from Rs 24.00 million.
Pasupati Acrylon’s operating profit of Rs 421.00 million for the quarter significantly outpaced the Rs 87.10 million reported in the corresponding period last year.
Diverse Quarterly Performances Across Companies
Other companies also announced their financial results for the June 2026 quarter, presenting a mixed bag of performances across various sectors.
- Univastu India reported a PAT of Rs 100.00 million.
- Hitachi Energy India posted a PAT of Rs 2941.50 million.
- Venmax Drugs & Pharma recorded a PAT of Rs 1.18 million.
- Morgan Ventures reported a Net Loss (PAT) of Rs -23.42 million for the quarter.
The June 2026 quarter has revealed a varied financial landscape, with some entities like Pasupati Acrylon demonstrating exceptional growth, while others navigated different trajectories, including a net loss for Morgan Ventures.